High neutrophil-to-lymphocyte ratio before starting anti-PD1 immunotherapy predicts poor outcome in patients with metastatic melanoma

Publication date: Available online 12 March 2018
Source:Journal of the American Academy of Dermatology
Author(s): Margaux Garnier, Julia Zaragoza, Nathalie Bénéton, Guido Bens, Victoire Meurisse, Mahtab Samimi, Hervé Maillard, Laurent Machet




http://ift.tt/2pbPqZl